Literature DB >> 6256764

Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA.

J Brandsma, G Miller.   

Abstract

A simple nucleic acid hybridization method to screen numerous samples of eukaryotic cells rapidly for their Epstein-Barr virus (EBV) DNA content is described. Whole cells are spotted on nitrocellulose filters and their DNA is denatured and fixed to the filter. The resultant DNA spots are hybridized to nick-translated EBV DNA and the extent of hybridization is monitored by autoradiography and scintillation counting. Statistical analysis of serial dilutions of cells permits their viral genome content to be estimated quantitatively by reference to a known standard, such as Raji cells or an artificial mixture of pure viral DNA and uninfected lymphocytes. The sensitivity of the method is between 5 and 50 pg of viral DNA. With this method we are able to select subclones that are high produces of EBV DNA and to identify the optimal time for harvest of EBV DNA from cultured cells. Spot hybridization should permit any cell population or fluid to be screened for the presence of a DNA sequence for which a radioisotopically labeled probe is available.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256764      PMCID: PMC350388          DOI: 10.1073/pnas.77.11.6851

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol.

Authors:  A Adams
Journal:  J Gen Virol       Date:  1973-09       Impact factor: 3.891

3.  Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics.

Authors:  M Nonoyama; J S Pagano
Journal:  Nature       Date:  1973-03-02       Impact factor: 49.962

4.  Loss of simian virus 40 DNA-RNA hybrids from nitrocellulose membranes; implications for the study of virus--host DNA interactions.

Authors:  M Haas; M Vogt; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

5.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

6.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

7.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

8.  Reassociation kinetics for Epstein-Barr virus DNA: nonhomology to mammalian DNA and homology of viral DNA in various diseases.

Authors:  Y Kawai; M Nonoyama; J S Pagano
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  67 in total

1.  The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.

Authors:  E A Hurley; L D Klaman; S Agger; J B Lawrence; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Characterisation by molecular hybridization of RNA fragments isolated from ancient (1400 B.C.) seeds.

Authors:  F Rollo
Journal:  Theor Appl Genet       Date:  1985-12       Impact factor: 5.699

3.  [Technic of nucleic acid hybridization and its significance for diagnostic problems].

Authors:  R Neumann
Journal:  Naturwissenschaften       Date:  1987-03

4.  DNA Probe for Lactobacillus delbrueckii.

Authors:  M Delley; B Mollet; H Hottinger
Journal:  Appl Environ Microbiol       Date:  1990-06       Impact factor: 4.792

5.  Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.

Authors:  S Schlager; S H Speck; M Woisetschläger
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.

Authors:  M Bodescot; M Perricaudet; P J Farrell
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

7.  Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection.

Authors:  P Price; J G Winter; S Nikoletti; J B Hudson; G R Shellam
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

8.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  L R Stanberry; S Kit; M G Myers
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

9.  When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

Authors:  E A Hurley; S Agger; J A McNeil; J B Lawrence; A Calendar; G Lenoir; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Characterization of trimethoprim resistance by use of probes specific for transposon Tn7.

Authors:  L Pulkkinen; P Huovinen; E Vuorio; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.